AstraZeneca Pharma India Limited (ASTRAZEN.BO)
INR 6485.35
(0.07%)
INR 6485.35
(0.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.71 Billion INR | 12.27% |
| 2022 | 1.5 Billion INR | 111.38% |
| 2021 | 714.3 Million INR | -36.71% |
| 2020 | 1.12 Billion INR | 9.06% |
| 2019 | 1.03 Billion INR | 81.78% |
| 2018 | 569.3 Million INR | 66.51% |
| 2017 | 341.9 Million INR | 58.14% |
| 2016 | 216.2 Million INR | 3248.16% |
| 2015 | -6.86 Million INR | 96.57% |
| 2014 | -200.48 Million INR | 48.89% |
| 2013 | -392.25 Million INR | 54.0% |
| 2012 | -852.73 Million INR | -464.42% |
| 2011 | 233.99 Million INR | -75.53% |
| 2010 | 956.32 Million INR | 6.69% |
| 2009 | 896.34 Million INR | -25.02% |
| 2008 | 1.19 Billion INR | 25.82% |
| 2007 | 950.09 Million INR | 35.06% |
| 2006 | 703.43 Million INR | 8.6% |
| 2005 | 647.76 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 341.6 Million INR | -25.13% |
| 2023 Q2 | 490.85 Million INR | -22.64% |
| 2023 Q1 | 634.47 Million INR | 171.61% |
| 2023 Q4 | 456.24 Million INR | 301.9% |
| 2023 Q3 | 113.52 Million INR | -76.87% |
| 2023 FY | 1.69 Billion INR | 12.27% |
| 2022 Q3 | 324.56 Million INR | -13.3% |
| 2022 Q4 | 233.6 Million INR | -28.03% |
| 2022 Q1 | 233.73 Million INR | -30.34% |
| 2022 Q2 | 374.37 Million INR | 60.17% |
| 2022 FY | 1.5 Billion INR | 111.38% |
| 2021 Q3 | 111.61 Million INR | -18.18% |
| 2021 Q4 | 335.53 Million INR | 200.63% |
| 2021 FY | 714.3 Million INR | -36.71% |
| 2021 Q1 | 108.7 Million INR | -68.55% |
| 2021 Q2 | 136.4 Million INR | 25.49% |
| 2020 Q2 | 311.34 Million INR | 16.79% |
| 2020 FY | 1.12 Billion INR | 9.06% |
| 2020 Q4 | 345.67 Million INR | 34.86% |
| 2020 Q3 | 256.33 Million INR | -17.67% |
| 2020 Q1 | 266.58 Million INR | 99.51% |
| 2019 Q1 | 339.24 Million INR | 531.06% |
| 2019 Q2 | 320.79 Million INR | -5.44% |
| 2019 Q3 | 354.53 Million INR | 10.52% |
| 2019 Q4 | 133.61 Million INR | -62.31% |
| 2019 FY | 1.03 Billion INR | 81.78% |
| 2018 FY | 569.3 Million INR | 66.51% |
| 2018 Q3 | 405.94 Million INR | 181.05% |
| 2018 Q4 | -78.7 Million INR | -119.39% |
| 2018 Q1 | 91.51 Million INR | -34.89% |
| 2018 Q2 | 144.43 Million INR | 57.82% |
| 2017 Q4 | 140.56 Million INR | 218.96% |
| 2017 Q3 | -118.16 Million INR | -134.35% |
| 2017 Q2 | 343.96 Million INR | 380.2% |
| 2017 Q1 | 71.63 Million INR | 460.19% |
| 2017 FY | 341.9 Million INR | 58.14% |
| 2016 Q2 | 9.92 Million INR | -93.59% |
| 2016 Q4 | -19.88 Million INR | -109.47% |
| 2016 Q3 | 210.02 Million INR | 2015.24% |
| 2016 FY | 216.2 Million INR | 3248.16% |
| 2016 Q1 | 154.97 Million INR | 385.4% |
| 2015 FY | -6.86 Million INR | 96.57% |
| 2015 Q4 | -54.3 Million INR | -162.6% |
| 2015 Q3 | 86.74 Million INR | 229.68% |
| 2015 Q2 | -66.89 Million INR | -346.24% |
| 2015 Q1 | 27.16 Million INR | -93.03% |
| 2014 Q4 | 389.54 Million INR | 390.51% |
| 2014 FY | -200.48 Million INR | 48.89% |
| 2014 Q1 | -176 Million INR | 57.89% |
| 2014 Q2 | -279.6 Million INR | -58.86% |
| 2014 Q3 | -134.09 Million INR | 52.04% |
| 2013 Q4 | -417.93 Million INR | -2853.4% |
| 2013 FY | -392.25 Million INR | 54.0% |
| 2013 Q1 | 17.68 Million INR | 105.27% |
| 2013 Q2 | -7.17 Million INR | -140.57% |
| 2013 Q3 | 15.17 Million INR | 311.55% |
| 2012 Q3 | -176.95 Million INR | 14.99% |
| 2012 Q2 | -208.16 Million INR | -57.9% |
| 2012 Q1 | -131.83 Million INR | 75.88% |
| 2012 FY | -852.73 Million INR | -464.42% |
| 2012 Q4 | -335.78 Million INR | -89.76% |
| 2011 Q4 | -546.63 Million INR | -348.47% |
| 2011 Q3 | 219.99 Million INR | 0.0% |
| 2011 FY | 233.99 Million INR | -75.53% |
| 2010 FY | 956.32 Million INR | 6.69% |
| 2009 FY | 896.34 Million INR | -25.02% |
| 2008 FY | 1.19 Billion INR | 25.82% |
| 2007 FY | 950.09 Million INR | 35.06% |
| 2006 FY | 703.43 Million INR | 8.6% |
| 2005 FY | 647.76 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 19.67 Billion INR | 91.272% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -275.374% |
| Sigachi Industries Limited | 1.47 Billion INR | -16.528% |
| Bal Pharma Limited | 233.9 Million INR | -634.26% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | 61.147% |
| Medico Remedies Limited | 100.3 Million INR | -1612.363% |
| Lasa Supergenerics Limited | -458 Million INR | 474.996% |
| Venus Remedies Limited | 534.65 Million INR | -221.238% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 141.737% |
| Alpa Laboratories Limited | 184.49 Million INR | -830.909% |
| Nectar Lifesciences Limited | 923.8 Million INR | -85.916% |
| Shilpa Medicare Limited | 1.36 Billion INR | -25.707% |
| Aarti Drugs Limited | 7.14 Billion INR | 75.975% |
| Lupin Limited | 28.04 Billion INR | 93.876% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 95.93% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 96.016% |
| Windlas Biotech Limited | 1.29 Billion INR | -32.228% |
| Suven Life Sciences Limited | -1.22 Billion INR | 240.11% |
| Eris Lifesciences Limited | 5.18 Billion INR | 66.855% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 87.975% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 144.577% |
| Ipca Laboratories Limited | 7.98 Billion INR | 78.479% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -39.521% |
| Achyut Healthcare Limited | 4.43 Million INR | -38599.865% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 98.353% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| RPG Life Sciences Limited | 2.29 Billion INR | 25.075% |
| Mankind Pharma Limited | 21.51 Billion INR | 92.018% |
| Laurus Labs Limited | 3.94 Billion INR | 56.504% |
| Piramal Pharma Limited | 4.55 Billion INR | 62.31% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -589.064% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 93.221% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 70.172% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 73.587% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -174.142% |
| Wanbury Limited | 569.71 Million INR | -201.466% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 62.725% |
| Wockhardt Limited | -670 Million INR | 356.343% |
| Themis Medicare Limited | 392.58 Million INR | -337.48% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -238.004% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 66.901% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 80.872% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 97.464% |
| Divi's Laboratories Limited | 33.08 Billion INR | 94.808% |
| NATCO Pharma Limited | 25.96 Billion INR | 93.385% |
| Gufic Biosciences Limited | 1.32 Billion INR | -29.144% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -7.559% |
| Ind-Swift Limited | 1.22 Billion INR | -40.094% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 38.352% |
| FDC Limited | 2.98 Billion INR | 42.486% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 1230.254% |
| Granules India Limited | 6.81 Billion INR | 74.805% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Alkem Laboratories Limited | 19.46 Billion INR | 91.175% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -18838.767% |
| Brooks Laboratories Limited | 14.44 Million INR | -11794.044% |
| Megasoft Limited | -121.1 Million INR | 1518.203% |
| ZIM Laboratories Limited | 253.82 Million INR | -576.637% |
| Strides Pharma Science Limited | 5.22 Billion INR | 67.134% |
| Neuland Laboratories Limited | 5.31 Billion INR | 67.705% |
| Morepen Laboratories Limited | 4.17 Billion INR | 58.851% |
| Hikal Limited | 32.11 Million INR | -5248.801% |
| Indoco Remedies Limited | 1.29 Billion INR | -32.877% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 45.095% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -725.523% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -6155.008% |
| Hester Biosciences Limited | 364.81 Million INR | -370.793% |